Animal Genomics Market Report 2034

Report Description

This report is updated with the latest market data and insights as of June 2026. Base year: 2025  |  Forecast period: 2026-2034

Animal Genomics Market Outlook

As per our latest research, the global animal genomics market size reached USD 8.4 billion in 2025, reflecting robust expansion across the sector. The market is projected to grow at a CAGR of 7.5% from 2026 to 2034, with the total value anticipated to reach USD 16.2 billion by 2034. This growth is primarily driven by increasing demand for sustainable livestock production, technological advancements in genomics, and heightened awareness regarding animal health and productivity. The integration of genomics in animal breeding and disease management is transforming the industry, offering unprecedented opportunities for precision agriculture and veterinary science. The broader adoption of veterinary genomics solutions across clinical and commercial settings is further reinforcing the market's upward trajectory.

Get Free Sample Report

A significant growth factor in the animal genomics market is the rising global demand for animal protein, which is pushing livestock producers to adopt advanced breeding techniques. Genomic selection enables the identification of animals with superior traits, resulting in healthier and more productive livestock. This not only increases yield but also reduces costs associated with disease and poor productivity. Furthermore, governments and private organizations are investing heavily in animal health and genetic research, further propelling the adoption of genomics solutions. The need to meet stringent food safety regulations and improve traceability in animal-derived food products also supports the market's expansion.

Another key driver is the rapid technological advancement in sequencing and bioinformatics tools, which has made genetic analysis more accessible and cost-effective. Next-generation sequencing (NGS), polymerase chain reaction (PCR), and microarray technologies have revolutionized the ability to analyze and interpret animal genomes at scale. These innovations have enabled researchers and breeders to quickly identify genetic markers associated with disease resistance, productivity, and other economically important traits. The falling cost of sequencing and improved data analytics capabilities are encouraging both large-scale commercial operations and smaller farms to integrate genomics into their routine practices, thereby expanding the market's reach significantly.

The growing emphasis on animal welfare and sustainable agriculture is also fueling market growth. Consumers are increasingly concerned about the ethical treatment of animals and the environmental impact of livestock production. Genomics provides tools for selective breeding programs that enhance animal health, reduce the need for antibiotics, and minimize environmental footprints. This aligns with global trends toward responsible farming and supports the market's long-term growth. Additionally, collaborations between academia, government, and industry players are accelerating research and development in animal genomics, fostering innovation and the commercialization of novel products and services. The convergence of genomics with artificial intelligence and big data analytics is opening new frontiers in predictive modeling and precision animal management.

From a regional perspective, North America currently leads the animal genomics market, accounting for approximately 37.5% of the total market value in 2025, followed by Europe and Asia Pacific. The United States benefits from well-established research infrastructure, high adoption rates of advanced technologies, and strong government support for agricultural innovation. Meanwhile, Asia Pacific is expected to witness the fastest growth during the forecast period, driven by increasing livestock populations, rising investments in genomics research, and growing awareness about animal health and productivity. Europe also remains a significant market, supported by strict regulatory frameworks and a focus on sustainable agriculture.

In addition to these advancements, the field of Animal Cloning is gaining attention as a complementary technology to genomics. Animal cloning involves creating a genetically identical copy of an animal, which can be particularly useful in preserving valuable genetic traits in livestock. This technology can be used to replicate animals with superior genetic profiles, ensuring that desirable traits such as disease resistance or high productivity are maintained across generations. While animal cloning is not yet widespread, its potential to enhance breeding programs and contribute to genetic diversity makes it a promising area of research. The integration of cloning with genomics could offer new solutions for sustainable livestock production, addressing challenges related to food security and environmental impact.

Product Type Analysis

The animal genomics market is segmented by product type into instruments, consumables, and services, each playing a critical role in the genomics workflow. Instruments such as sequencers, PCR machines, and microarray platforms are essential for conducting genetic analysis. The demand for advanced instruments is continuously rising as laboratories and research institutes seek to enhance throughput and accuracy. Technological advancements have led to the development of more compact, user-friendly, and automated instruments, which are increasingly being adopted by both large and small-scale users. The high initial investment required for instruments is often offset by their long-term utility and the critical role they play in genomics research and diagnostics. Instruments accounted for approximately 34.5% of the total market in 2025.

Get Free Sample Report

Consumables represent the largest portion of the animal genomics market at approximately 42.8% in 2025, encompassing reagents, kits, and other expendable materials required for genomic analysis. The recurring need for consumables in every testing cycle ensures a steady and predictable revenue stream for market players. Innovations in kit formulations and reagent chemistry have improved the sensitivity and specificity of genomic assays, driving their adoption in diverse applications such as disease diagnostics, breeding programs, and trait selection. The growing demand for high-throughput testing and multiplex assays further fuels the consumables segment, making it one of the most dynamic areas in the animal genomics value chain. For a deeper look at how consumables and testing services intersect, the broader landscape of animal genetic testing offers additional context on adoption trends and demand drivers.

Services form another vital segment at approximately 22.7% of the 2025 market, comprising genetic testing, sequencing, bioinformatics analysis, and consulting. As genomic data becomes increasingly complex, the need for expert interpretation and data management has surged. Service providers offer end-to-end solutions, from sample collection and sequencing to data analysis and reporting, catering to research institutes, veterinary hospitals, and commercial breeders. Outsourcing genomics services allows organizations to access cutting-edge technologies and expertise without investing in expensive infrastructure, thereby broadening market access. The rise of cloud-based bioinformatics platforms and remote consulting services further strengthens this segment's growth outlook through 2034.

The interplay between instruments, consumables, and services creates a synergistic market environment. As new instruments are launched, compatible consumables and specialized services are developed in tandem, ensuring a seamless workflow for end-users. This integrated approach accelerates the adoption of genomics technologies and fosters innovation across the product ecosystem. Companies are increasingly focusing on offering bundled solutions that combine instruments, consumables, and services, providing comprehensive value propositions to their customers and enhancing market competitiveness. The shift toward subscription-based service models and platform-as-a-service offerings is also reshaping revenue dynamics across all three product type segments.

Report Scope

Application Analysis

The application landscape of the animal genomics market is diverse, encompassing genetic disease research, animal breeding, livestock health, veterinary clinics, and other specialized uses. Genetic disease research remains a cornerstone application, enabling the identification of hereditary disorders and the development of targeted interventions. Animal genomics facilitates the detection of disease-associated genetic markers, paving the way for early diagnosis and the design of preventive strategies. This not only improves animal welfare but also reduces economic losses associated with disease outbreaks, making genomics an indispensable tool in modern veterinary science. Research into animal nutrigenomics is also gaining momentum, exploring how genetic makeup influences nutritional requirements and metabolic responses in livestock and companion animals.

Animal breeding is another major application area, leveraging genomics to enhance desirable traits such as growth rate, milk yield, disease resistance, and reproductive performance. Genomic selection allows breeders to make informed decisions based on genetic merit, accelerating the development of superior livestock lines. This is particularly important in the context of global food security, as efficient breeding programs contribute to increased productivity and sustainability. The integration of genomics in breeding programs is supported by advances in sequencing technologies and bioinformatics, which enable the rapid analysis of large populations and the identification of valuable genetic variants. Solutions focused specifically on livestock genomic selection are becoming increasingly sophisticated, incorporating multi-trait models and genomic-estimated breeding values to drive faster genetic gains.

Livestock health management is increasingly reliant on genomics for disease surveillance, outbreak investigation, and the development of vaccines and therapeutics. Genomic tools enable the monitoring of pathogen evolution, the identification of resistance genes, and the tracking of disease transmission pathways. This information is critical for designing effective control measures and ensuring the long-term health of livestock populations. The application of genomics in veterinary clinics is also expanding, with genetic testing being used to diagnose inherited conditions, guide treatment decisions, and inform breeding recommendations for companion animals.

Other applications in the animal genomics market include traceability, food safety, and conservation biology. Genomics-based traceability systems enhance transparency in the food supply chain, helping to meet regulatory requirements and consumer expectations for quality and safety. Conservation programs use genomics to monitor genetic diversity and manage endangered species, supporting biodiversity and ecosystem health. The versatility of genomics technologies ensures their relevance across a wide range of applications, driving continuous innovation and market growth well into the 2026-2034 forecast period.

Species Analysis

The animal genomics market is segmented by species into cattle, poultry, swine, aquaculture, companion animals, and others. Cattle represent the largest segment, driven by the high economic value of beef and dairy production worldwide. Genomics is widely used in cattle breeding programs to improve traits such as milk yield, meat quality, and disease resistance. The adoption of genomic selection in cattle is supported by large-scale genotyping projects and the availability of comprehensive reference genomes, which facilitate the identification of valuable genetic markers and the implementation of precision breeding strategies.

Poultry is another significant segment, reflecting the global demand for chicken meat and eggs. Genomics plays a critical role in improving production efficiency, disease resistance, and product quality in poultry. The short generation intervals and large population sizes in poultry breeding make genomics particularly effective for rapid genetic improvement. Swine genomics is also gaining traction, with applications in breeding for lean meat, reproductive traits, and resistance to diseases such as porcine reproductive and respiratory syndrome (PRRS). The integration of genomics in swine production supports the development of healthier and more productive herds. The growing complexity of these programs is well captured in dedicated research on genomic testing for livestock, which outlines key testing methodologies and commercial adoption patterns.

Aquaculture, encompassing fish and shellfish, is one of the fastest-growing areas of focus in the animal genomics market. Genomics is used to enhance growth rates, disease resistance, and environmental adaptability in farmed aquatic species. As global fish consumption rises, the application of genomics in aquaculture is expanding rapidly, supporting sustainable production and resource management. Detailed insights into species-specific platforms and breeding tools are available in dedicated coverage of the aquaculture genomics segment, which highlights the increasing investment in salmon, tilapia, and shrimp genomics programs. Companion animals, including dogs, cats, and horses, represent a growing segment, with genomics being used for breed identification, inherited disease testing, and personalized veterinary care.

Other species, such as sheep, goats, and exotic animals, also benefit from genomics applications, particularly in regions where these animals play a significant economic or cultural role. The development of species-specific genomic tools and resources is enabling the extension of genomics benefits to a broader range of animals, supporting genetic improvement, disease management, and conservation efforts across diverse species. The ongoing expansion of reference genomes and genotyping platforms is expected to further democratize access to genomics technologies, driving growth across all species segments through 2034.

Technology Analysis

Technological innovation is at the heart of the animal genomics market, with key segments including PCR, microarrays, sequencing, bioinformatics, and other emerging technologies. Polymerase chain reaction (PCR) remains a foundational tool for amplifying and detecting specific genetic sequences, supporting applications in disease diagnostics, genotyping, and research. The widespread availability of PCR instruments and reagents, coupled with continuous improvements in sensitivity and throughput, ensures the ongoing relevance of this technology in animal genomics workflows in 2025 and beyond.

Microarrays offer high-throughput genotyping capabilities, enabling the simultaneous analysis of thousands of genetic markers. This technology is particularly valuable for large-scale breeding programs and population studies, where rapid and cost-effective screening is essential. Microarrays have been instrumental in the identification of trait-associated markers and the development of genomic selection strategies in livestock and poultry. However, the rise of next-generation sequencing (NGS) is gradually shifting the market landscape, as sequencing offers greater resolution and the ability to discover novel variants across the genome.

Sequencing technologies, including whole-genome, exome, and targeted sequencing, are driving a paradigm shift in animal genomics. The falling cost of sequencing and advances in data analysis have made it feasible to conduct comprehensive genomic studies in a wide range of species. Sequencing enables the identification of rare and complex genetic variants, supports the development of reference genomes, and underpins precision breeding and disease management strategies. Long-read sequencing platforms from companies such as Pacific Biosciences are adding further resolution to structural variant detection, broadening the scope of genomic discovery in both model and non-model species.

Bioinformatics is an essential enabler of animal genomics, providing the computational tools and expertise required to manage, analyze, and interpret large volumes of genomic data. Advances in artificial intelligence, machine learning, and cloud computing are enhancing the speed and accuracy of bioinformatics pipelines, making it easier for researchers and breeders to extract actionable insights from complex datasets. Other emerging technologies, such as CRISPR-based gene editing, digital PCR, and spatial transcriptomics, are poised to further expand the capabilities of animal genomics, supporting the development of novel applications and solutions across the 2026-2034 forecast horizon.

End-User Analysis

The end-user landscape of the animal genomics market is diverse, encompassing research institutes, veterinary hospitals, diagnostic laboratories, and other specialized organizations. Research institutes are at the forefront of genomics innovation, conducting fundamental and applied research to advance our understanding of animal genetics and improve breeding and health outcomes. These institutions often collaborate with industry partners, government agencies, and international organizations to drive large-scale genomics projects and develop new technologies and standards.

Veterinary hospitals are increasingly adopting genomics-based diagnostics and treatment strategies to enhance animal care. Genetic testing is used to diagnose inherited diseases, guide therapeutic decisions, and inform breeding recommendations for both livestock and companion animals. The integration of genomics into veterinary practice is supported by advances in point-of-care testing, user-friendly data analysis tools, and continuing education for veterinary professionals. Diagnostic laboratories play a critical role in delivering high-throughput genotyping, sequencing, and bioinformatics services to a wide range of clients, including breeders, farmers, and veterinarians.

Other end-users include government agencies, breeding companies, and animal health organizations, which leverage genomics for disease surveillance, regulatory compliance, and the development of new products and services. The increasing availability of outsourced genomics services and cloud-based data analysis platforms is democratizing access to advanced technologies, enabling smaller organizations and individual producers to benefit from genomics insights. This broadening of the end-user base is expected to drive market growth and foster innovation across the animal genomics ecosystem through 2034.

The interplay between different end-user segments creates a dynamic and collaborative market environment. Partnerships between research institutes, commercial providers, and end-users are accelerating the translation of scientific discoveries into practical solutions, supporting the adoption of genomics across the animal health and agriculture sectors. The ongoing professionalization and specialization of genomics services are expected to further enhance the value proposition for end-users, driving sustained market expansion. Resources covering the breadth of the livestock genetics sector provide useful comparative context for understanding how end-user demand is evolving across different production systems and geographies.

Opportunities & Threats

The animal genomics market presents numerous opportunities for growth and innovation, particularly in the areas of precision breeding, disease management, and sustainable agriculture. The ongoing digitization of agriculture and the integration of genomics with other technologies such as artificial intelligence, big data analytics, and IoT are creating new possibilities for data-driven decision-making and predictive modeling. These advancements enable more precise and efficient selection of animals with desirable traits, reducing production costs and environmental impacts while improving animal welfare. The development of portable and cost-effective genomic testing platforms is also expanding access to genomics solutions in resource-limited settings, supporting the global adoption of advanced breeding and health management practices.

Another significant opportunity lies in the expansion of genomics applications beyond traditional livestock and poultry species. The growing interest in aquaculture, companion animals, and wildlife conservation is opening up new markets for genomics products and services. The increasing humanization of pets, coupled with rising demand for personalized veterinary care, is driving the adoption of genomics in the companion animal segment. In addition, the use of genomics in conservation biology and biodiversity management is gaining traction, supported by international efforts to preserve endangered species and ecosystems. These emerging applications are expected to diversify revenue streams and foster innovation across the animal genomics market through the 2026-2034 forecast period.

Despite these opportunities, the market faces several restraining factors, including high initial investment costs, complex regulatory environments, and challenges related to data privacy and ethical considerations. The adoption of advanced genomics technologies often requires significant capital expenditure and specialized expertise, which may be prohibitive for smaller organizations and producers. Regulatory requirements for genetic testing and data management vary widely across regions, creating uncertainty and compliance challenges for market participants. Concerns about the ethical use of genetic information and the potential for unintended consequences in breeding programs also pose risks to market growth. Addressing these challenges will require ongoing investment in education, infrastructure, and regulatory harmonization, as well as transparent communication with stakeholders and the public.

Regional Outlook

North America dominates the global animal genomics market, accounting for approximately 37.5% of the total market value in 2025, which translates to around USD 3.15 billion. The region's leadership is attributed to its advanced research infrastructure, high adoption rates of cutting-edge technologies, and substantial government and private sector investments in genomics. The United States, in particular, is a major hub for animal genomics research and commercialization, supported by strong collaborations between academia, industry, and government agencies. The presence of leading market players and a robust regulatory framework further reinforce North America's position as a key driver of market growth and innovation. The region is projected to maintain steady growth at a CAGR of approximately 7.1% through 2034.

Get Free Sample Report

Europe represents the second-largest market, with a 2025 value of approximately USD 2.12 billion, driven by stringent food safety regulations, a focus on sustainable agriculture, and a well-established research ecosystem. Countries such as Germany, the United Kingdom, France, and the Netherlands are at the forefront of genomics adoption, leveraging advanced technologies to improve livestock productivity and animal health. The European market is characterized by strong regulatory oversight and a commitment to ethical and sustainable practices, which support the integration of genomics into breeding and health management programs. The region is expected to maintain steady growth, with a projected CAGR of 6.9% through 2034.

Asia Pacific is poised for the fastest growth in the animal genomics market, with a 2025 market size of approximately USD 1.92 billion and a projected CAGR of 8.7% from 2026 to 2034. The region's rapid expansion is fueled by increasing livestock populations, rising investments in agricultural innovation, and growing awareness of the benefits of genomics for animal health and productivity. China, India, and Australia are leading the adoption of genomics technologies, supported by government initiatives, expanding research capabilities, and a burgeoning commercial sector. Latin America and the Middle East & Africa together account for the remaining share of the global market, with Latin America showing particular promise due to its large cattle and poultry industries and growing interest in precision livestock farming solutions.

Competitor Outlook

The animal genomics market is characterized by intense competition, with a diverse array of global and regional players vying for market share. The competitive landscape is shaped by continuous technological innovation, strategic partnerships, and a focus on expanding product portfolios to address the evolving needs of end-users. Leading companies are investing heavily in research and development to launch new instruments, consumables, and services that offer enhanced performance, accuracy, and ease of use. Mergers and acquisitions are also common, as companies seek to strengthen their market positions, access new technologies, and expand their geographic reach. This dynamic environment is creating a highly innovative market that is evolving rapidly in response to both scientific advances and shifting commercial demands.

The market is witnessing a trend toward the integration of genomics with other advanced technologies, such as artificial intelligence, machine learning, and cloud computing. This convergence is enabling the development of comprehensive solutions that streamline the entire genomics workflow, from sample collection and sequencing to data analysis and interpretation. Companies are increasingly offering bundled solutions that combine instruments, consumables, and services, providing end-users with seamless and cost-effective options. The emphasis on user-friendly platforms and remote services is also expanding market access, particularly in emerging markets and resource-limited settings across Latin America, Southeast Asia, and Sub-Saharan Africa.

Collaboration and partnership are central to the competitive dynamics of the animal genomics market. Leading players are forming alliances with research institutions, government agencies, and industry stakeholders to accelerate innovation, drive standardization, and facilitate the commercialization of new technologies. These collaborations are particularly important in the development of reference genomes, genotyping arrays, and bioinformatics tools that support the broader adoption of genomics across species and applications. The focus on open innovation and knowledge sharing is fostering a vibrant and dynamic market ecosystem, particularly in the development of cross-species genomic platforms.

Some of the major companies operating in the animal genomics market include Illumina, Inc., Thermo Fisher Scientific, Inc., Neogen Corporation, Zoetis, Inc., and Genus plc. Illumina is a global leader in sequencing and genotyping technologies, offering a comprehensive range of instruments, consumables, and services for animal genomics applications. Thermo Fisher Scientific provides a broad portfolio of genomics solutions, including PCR, microarrays, and bioinformatics tools, catering to research institutes, diagnostic laboratories, and commercial breeders. Neogen Corporation specializes in animal safety and genomics, delivering innovative testing solutions for livestock, poultry, and companion animals through its GeneSeek subsidiary. Zoetis is a leading animal health company, with a strong focus on genomics-based diagnostics and precision breeding. Genus plc is a pioneer in animal genetics, leveraging genomics to improve productivity and sustainability in livestock production across global markets.

Other notable players include IDEXX Laboratories, Inc., Eurofins Scientific SE, Agilent Technologies, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Pacific Biosciences of California, Inc., Mars Petcare (Wisdom Panel), Topigs Norsvin, CRV Holding B.V., Hendrix Genetics, and Inotiv, Inc. These companies are continuously expanding their product offerings, investing in research and development, and pursuing strategic acquisitions to maintain their competitive edge. They are also actively engaged in education and training initiatives to support the adoption of genomics technologies among end-users. The competitive landscape is expected to remain dynamic through 2034, with ongoing innovation and the entry of new digital-first players driving the evolution of the animal genomics market.

Key Players

• Illumina, Inc.
• Thermo Fisher Scientific, Inc.
• Neogen Corporation
• Zoetis, Inc.
• Genus plc
• IDEXX Laboratories, Inc.
• Eurofins Scientific SE
• Agilent Technologies, Inc.
• Qiagen N.V.
• Bio-Rad Laboratories, Inc.
• Mars Petcare (Wisdom Panel)
• GeneSeek (Neogen subsidiary)
• Topigs Norsvin
• CRV Holding B.V.
• GenoMar Genetics AS
• Animal Genetics, Inc.
• Pacific Biosciences of California, Inc.
• Hendrix Genetics
• Inotiv, Inc.
• Cooke Aquaculture